Corient Private Wealth’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
Corient Private Wealth's ORIC Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 39,094 shares worth $527K. The stake represents ﹤0.01% of the portfolio and ranks #2417 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in ORIC as recently as Q4 2025.
Corient Private Wealth first reported a position in ORIC in Q4 2025 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Corient Private Wealth held 39,094 shares of Oric Pharmaceuticals worth $527K as of Q3 2026.
- Oric Pharmaceuticals was a new Corient Private Wealth position in Q3 2026.
- Oric Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2417 holding.
- Corient Private Wealth first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 202 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.